Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacology
|
May 29, 1998
The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension
B E Ilson, D E Martin, S C Boike, et al.
Clinical Pharmacy
|
May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage
G R Matzke, J M Kovarik, M J Rybak, et al.
Hospital Pharmacy
|
August 7, 1989
An analysis of 1986 drug procurement practices in hospitals within the United States
R T Smolarek, M F Powell, D K Solomon, et al.
The Journal of Antimicrobial Chemotherapy
|
April 1, 1990
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
M J Rybak, L M Albrecht, S C Boike, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1986
Clinical use and toxicity of high-dose tobramycin in patients with pseudomonal endocarditis
M J Rybak, S C Boike, D P Levine, et al.
Clinical Pharmacology and Therapeutics
|
May 20, 1998
A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men
B E Ilson, S C Boike, D E Martin, et al.
British Journal of Clinical Pharmacology
|
June 1, 1997
Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers
D E Martin, D Tompson, S C Boike, et al.
Journal of Clinical Pharmacology
|
April 1, 1997
Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension
D E Everitt, S C Boike, J R Piltz-Seymour, et al.
Journal of Clinical Pharmacology
|
April 29, 1998
Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment
D E Martin, M C Chapelsky, B Ilson, et al.
Journal of Clinical Pharmacology
|
May 23, 1998
Bioequivalence assessment of a single 5 mg/day testosterone transdermal system versus two 2.5 mg/day systems in hypogonadal men
D E Wilson, A W Meikle, S C Boike, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacology
|
May 29, 1998
The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension
B E Ilson, D E Martin, S C Boike, et al.
Clinical Pharmacy
|
May 1, 1985
Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage
G R Matzke, J M Kovarik, M J Rybak, et al.
Hospital Pharmacy
|
August 7, 1989
An analysis of 1986 drug procurement practices in hospitals within the United States
R T Smolarek, M F Powell, D K Solomon, et al.
The Journal of Antimicrobial Chemotherapy
|
April 1, 1990
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
M J Rybak, L M Albrecht, S C Boike, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1986
Clinical use and toxicity of high-dose tobramycin in patients with pseudomonal endocarditis
M J Rybak, S C Boike, D P Levine, et al.
Clinical Pharmacology and Therapeutics
|
May 20, 1998
A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men
B E Ilson, S C Boike, D E Martin, et al.
British Journal of Clinical Pharmacology
|
June 1, 1997
Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers
D E Martin, D Tompson, S C Boike, et al.
Journal of Clinical Pharmacology
|
April 1, 1997
Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension
D E Everitt, S C Boike, J R Piltz-Seymour, et al.
Journal of Clinical Pharmacology
|
April 29, 1998
Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment
D E Martin, M C Chapelsky, B Ilson, et al.
Journal of Clinical Pharmacology
|
May 23, 1998
Bioequivalence assessment of a single 5 mg/day testosterone transdermal system versus two 2.5 mg/day systems in hypogonadal men
D E Wilson, A W Meikle, S C Boike, et al.
Page
of 4